RADFORSK, The Norwegian Radium Hospital Research Foundation strategic research area (2023-2028) (Co-PI) TARACAN: Targeted Radionuclide Therapy for disseminated cancer
South-Eastern Norway Regional Health Authority/Norwegian Cancer Society (2020-2024) Theranostic radiopharmaceuticals for metastatic cancer
South-Eastern Norway Regional Health Authority (2019-2024) A novel PET-based prediction platform for myeloma patients
South-Eastern Norway Regional Health Authority and CarciNor (2018-24) Clinical usefulness of advanced image analysis of 18F-FDG PET/CT for in vivo characterisation of neuroendocrine carcinomas
Civitan, The Alzheimer Research Fund (2018-2023) Amyloid imaging by 18F-Flutemetamol PET/CT and MRI – clinical value and quantitative reference levels
Stern NM, Mikalsen LTG, Dueland S, Schulz A, Line PD, Stokke C, Grut H(2024) The prognostic value of [18F]FDG PET/CT texture analysis prior to transplantation for unresectable colorectal liver metastases Clin Physiol Funct Imaging(in press) DOI 10.1111/cpf.12908, PubMed 39358976
Skingen VE, Salberg UB, Hompland T, Fjeldbo CS, Helgeland H, Frikstad KM, Ragnum HB, Vlatkovic L, Hole KH, Seierstad T, Lyng H(2024) Spatial analysis of microRNA regulation at defined tumor hypoxia levels reveals biological traits of aggressive prostate cancer J Pathol, 264(3), 270-283 DOI 10.1002/path.6344, PubMed 39329425
Galtung KF, Lauritzen PM, Sandbæk G, Bay D, Baco E, Rud E(2024) Urinary stone assessment in a single-phase may replace the unenhanced and multiphase computed tomography protocol in painless visible haematuria Scand J Urol, 59, 147-155 DOI 10.2340/sju.v59.40679, PubMed 39268780